Biofourmis
Fernand Lendoye is a financial and investment expert with extensive experience in fintech, insurtech, and healthtech. Currently serving as the Head of Fintech Ventures at HSBC Life since May 2022, Fernand is responsible for fostering innovations across Asia, Europe, and LATAM. As a founder and Managing Director of Klimrod & Co., a private investment vehicle, Fernand also invests in several companies including Biofourmis, Neuroglee Therapeutics, and MioTech. Prior roles include Co-Founder and Managing Director of Brightriver Capital, which focuses on providing capital to mid-sized Southeast Asian businesses, as well as General Partner at London Venture Factory. Fernand holds an MBA from The University of Chicago Booth School of Business and advanced management education from Stanford and MIT.
This person is not in any teams
This person is not in any offices
Biofourmis
6 followers
Biofourmis is a fast-growing digital health company filled with committed, passionate people who care about augmenting personalized care and empowering people with complex chronic conditions to live better and healthier lives. They are pioneering an entirely new category of medicine, by developing clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Biofourmis has built Biovitals®, a highly sophisticated personalized AI-powered health analytics platform that predicts clinical exacerbation in advance of a critical event, which is the backbone of their digital therapeutics’ product pipeline across multiple therapeutic areas—including heart failure, oncology, acute coronary syndrome, COPD and chronic pain.